![Joseph Romanelli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Romanelli
Director/Board Member at
KIMBERLY-CLARK CORPORATION
Net worth: 4 M $ as of 29/09/2026
Profile
Joseph Romanelli is currently President, Chief Executive Officer & Director at Tessera Therapeutics, Inc. since 2026.
Mr. Romanelli is Chief Executive Officer & Partner at Flagship Pioneering, LLC starting in 2026.
Mr. Romanelli serves as an Independent Director at Kimberly-Clark Corp.
beginning in 2024.
Former roles include Chief Executive Officer at CORXEL Pharmaceuticals (Shanghai) Co., Ltd. from 2021 to 2022.
Mr. Romanelli was Head-Investor Relations at Merck & Co., Inc. from 1996 to 2015.
Mr. Romanelli held the position of Head-Investor Relations at Schering-Plough Corp.
USA. Mr. Romanelli was President-Human Health International at Merck & Co., Inc. Education includes an undergraduate degree from the University of Delaware and an MBA from Gabelli School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 25/01/2026 | 28,739 ( 0% ) | 4 M $ | 29/09/2026 | |
| 01/01/2026 | 0 ( -.--% ) | - $ | 29/09/2026 |
Joseph Romanelli active positions
| Companies | Position | Start |
|---|---|---|
| KIMBERLY-CLARK CORPORATION | Director/Board Member | 12/11/2024 |
Tessera Therapeutics, Inc.
 Tessera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that writes therapeutic messages into the genome to treat diseases | Chief Executive Officer | 22/07/2026 |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Chief Executive Officer | 31/12/2025 |
Former positions of Joseph Romanelli
| Companies | Position | End |
|---|---|---|
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
 Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. BiotechnologyHealth Technology Develops and commercializes novel therapeutics for cardiometabolic diseases | Chief Executive Officer | 30/06/2022 |
| MERCK & CO., INC. | Investor Relations Contact | 30/06/2015 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Public Communications Contact | 03/11/2009 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Education of Joseph Romanelli
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
93
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Kimberly-Clark Corp.
 Kimberly-Clark Corp. Household/Personal CareConsumer Non-Durables Manufactures paper based products and provides cleaning solutions | Consumer Non-Durables |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gabelli School of Business
 Gabelli School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tessera Therapeutics, Inc.
Tessera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that writes therapeutic messages into the genome to treat diseases | Health Technology |
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. BiotechnologyHealth Technology Develops and commercializes novel therapeutics for cardiometabolic diseases | Health Technology |
- Stock Market
- Insiders
- Joseph Romanelli
